Ãëàâíàÿ    Ex Libris    Êíèãè    Æóðíàëû    Ñòàòüè    Ñåðèè    Êàòàëîã    Wanted    Çàãðóçêà    ÕóäËèò    Ñïðàâêà    Ïîèñê ïî èíäåêñàì    Ïîèñê    Ôîðóì   
blank
Àâòîðèçàöèÿ

       
blank
Ïîèñê ïî óêàçàòåëÿì

blank
blank
blank
Êðàñîòà
blank
Gomperts B.D., Tatham P.E.R., Kramer I.M. — Signal Transduction
Gomperts B.D., Tatham P.E.R., Kramer I.M. — Signal Transduction



Îáñóäèòå êíèãó íà íàó÷íîì ôîðóìå



Íàøëè îïå÷àòêó?
Âûäåëèòå åå ìûøêîé è íàæìèòå Ctrl+Enter


Íàçâàíèå: Signal Transduction

Àâòîðû: Gomperts B.D., Tatham P.E.R., Kramer I.M.

Àííîòàöèÿ:

Signal Transduction is a text reference on cellular signalling processes. Starting with the basics, it explains how cells respond to external cues (hormones, cytokines, neurotransmitters, adhesion molecules, extracellular matrix, etc), and shows how these inputs are integrated and co-ordinated. The first half of the book provides the conceptual framework, explaining the formation and action of second messengers, particulary cyclic nucleotides and calcium, and the mediation of signal pathways by GTP-binding proteins. The remaining chapters deal with the formation of complex signalling cascades employed by cytokines and adhesion molecules, starting at the membrane and ending in the nucleus, there to regulate gene transcription. In this context, growth is an important potential outcome and this has relevance to the cellular transformations that underlie cancer. The book ends with a description at the molecular level of how signalling proteins interact with their environment and with each other through their structural domains. Each main topic is introduced with a historical essay, detailing the sources key observations and experiments that set the scence for recent and current work.


ßçûê: en

Ðóáðèêà: Òåõíîëîãèÿ/

Ñòàòóñ ïðåäìåòíîãî óêàçàòåëÿ: Ãîòîâ óêàçàòåëü ñ íîìåðàìè ñòðàíèö

ed2k: ed2k stats

Ãîä èçäàíèÿ: 2002

Êîëè÷åñòâî ñòðàíèö: 424

Äîáàâëåíà â êàòàëîã: 21.12.2005

Îïåðàöèè: Ïîëîæèòü íà ïîëêó | Ñêîïèðîâàòü ññûëêó äëÿ ôîðóìà | Ñêîïèðîâàòü ID
blank
Ïðåäìåòíûé óêàçàòåëü
Cell cycle, adhesion molecules in regulation      328—330 330 331
Cell cycle, checkpoints      233 234 240 244
Cell cycle, cyclins expression      234—240 234
Cell cycle, phases      233 233 234—240
Cell cycle, transition points      234
Cell transformation      see “Transformation”
Ceramide      162 205
CFTR (cystic fibrosis transmembrane conductance regulator)      112
CGD (chronic granulomatous disease)      214 217
Checkpoint protein-kinase-1      see “Chk-1”
Checkpoint protein-kinase-2      see “Chk-2”
Chelating agents      148
Chemokine receptors      352 353
Chemokines      23 320 347 349 351—354 351
Chemotaxis      347
Chk-1 (checkpoint protein-kinase-1)      243
Chk-2 (checkpoint protein-kinase-2)      243
Chlorpromazine      48
Cholecystokinin      19 20
Cholera toxin      116—119
Cholinergic receptors      38—42
Chromatid segregation      238 239 240 244—245
Chronic granulomatous disease      see “CGD”
CICR ($Ca^{2+}$-induced $Ca^{2+}$ release)      155 167 182
Clonidine      36 37 62
Cohesin      244 245
Conductin      333
cones      130
Contact inhibition      334
CRE (cyclic AMP response element)      194
CREB (cyclic AMP response element binding protein)      194—195 194
CREB binding protein      see “CBP”
CrkL      263
Csk (C-terminal Src kinase)      295 409
CTP (cytidine triphosphate)      71
Cullin      see “Cdc53”
Curare      15 16
CXC chemokines      351 357 352
Cyclic ADP-ribose      see “cADPr”
Cyclic AMP      25 62 107—109
Cyclic AMP response element      see “CRE”
Cyclic AMP response element binding protein      see “CRB”
Cyclic AMP, $Ca^{2+}$ signalling convergence      176
Cyclic AMP, 7TM receptor signalling      54 55
Cyclic AMP, cellular response estimation      27 29
Cyclic AMP, formation from ATP      109 109 110
Cyclic AMP, historical aspects      31—32 107
Cyclic AMP, ion channel regulation      197
Cyclic AMP, phosphorylation-related signal amplification      191—192
Cyclic AMP, PKA activation      192—193 193
Cyclic AMP, suppression by $\beta 1$ adrenergic antagonists      36
Cyclic AMP, theophylline actions      30 31
Cyclic AMP-dependent protein kinase      see “PKA”
Cyclic GMP visual transduction      127 133—135
Cyclic GMP-dependent kinase      see “G kinase”
Cyclin A      235 236 237
Cyclin B      237 238 240 243
Cyclin D      211 235 236 236 240 241 330
Cyclin E      211 235 236 241 246 330
Cyclin H      235
Cyclin-dependent protein kinases      see “CDKs”
Cyclins      234 234
Cyclins, cell cycle expression      234—240 234
Cyclins, cell cycle expression, G1 phase      235—236 235 236
Cyclins, cell cycle expression, G2 phase      237—238 237
Cyclins, cell cycle expression, mitosis      238—240
Cyclins, cell cycle expression, S phase      236—237
Cyclophilin      388 390
Cyclosporin      190 388 390
Cystic fibrosis transmembrane conductance regulator      see “CFTR”
Cytidine triphosphate      see “CTP”
Cytochrome c, apoptosis regulation      339—340 340
Cytokines      22—23 232
Cytokines, inflammatory mediators      213 345
Cytokines, signalling pathways      291
Cytoskeleton      180
Cytoskeleton, adhesion molecule linkage      317 319 325 328 331
Cytoskeleton, rearrangement at mitosis      238
Cytotoxic T lymphocytes      284 285 317
D-Ras      86
daf 1 to daf 4      361 365 365
DAG (diacylglycerol)      25 115 120 179 261 265 285
DAG kinase      179
DAG, PKC activation      198 199 201 203 203 215
DAG, PKC activation, sources      204—205 204
Dephosphorylation      189 190 373—383 374
Dephosphorylation, CREB      195—196
Dephosphorylation, negative regulation      379—383
Desensitization, homologous/heterologous of phosphorylated receptors      85
Desensitization, nicotinic receptors      49—50
Desensitization, proteinase activated receptors (PARs)      58
Desmoplakin      331
Desmosomes      322 322 331—332
DFP (diisopropyl fluorophosphate)      49
DHPR      159 165 166 182
Diacylglycerol      see “DAG”
Differentiation      22
Differentiation, role of adherent junctions      332
Dihydrofolate reductase      237
Dihydropyridines      157
Diisopropyl fluorophosphate      see “DFP”
Dissociation constant (KD)      26 27 31
DNA helicase      237
DNA polymerase      237
DNA repair      243—244
DNA-PK (DNA-dependent protein kinase)      337
Dopamine      33 34
Dopamine receptors      61
Downstream of receptor kinases      see “Drk”
DP-1      235
dpp      359 364 365
Drk (downstream of receptor kinases)      267—268
Drosophila, $TGF\beta$ receptor homologues      361 364—365
Drosophila, MAP kinases      275
Drosophila, photoreceptor development      266—268 267 268
Drosophila, phototransduction      141 142 158 206—208 207
Drosophila, Ras proteins      86
Drosophila, Smad homologues      366 368
Drosophila, tyrosine phosphatases      377 378
E-selectin      323 351 354
E2F      235 236 242
E6 protein      243
EC50      27—28 29 30 31
EF-2 kinase (elongation factor-2 kinase)      275
EF-hand motifs      171 173 174 177 179 180 183 401—402 402
EGF (epidermal growth factor)      20
EGF receptor      4 229 249
EGF receptor, activation      259 261 265 271
EGF, historical aspects      227—230 229
EGTA      148 148 181
Eicosanoids      23
Eicosanoids, receptor binding      55
EILDV motifs      318
ELAM-1      318
Electric organs      42—43
eLF-4E      272 273 307—308
Elongation factor-2 kinase      see “EF-2 kinase”
Endocytosis      31 84
Endoglin      362
Endonexin fold      172
Endorphins      3
Endothelial cell adhesion molecules      349—351
Epac      197—198 198
Ephedrine      2 37
Epidermal growth factor      see “EGF”
Epidermolysis bullosa      332
Epinephrine      see “Adrenaline”
EPO (erythropoietin)      284
Epo receptor      284 380—381
Equilibrium constant      26
Erb-B      229 230 249
Ergot      11 12—14
Ergotamine      14
ERK (extracellular signal regulated protein kinase)      80 84 92 210 270 271 274 330
ERK, activation      196—197 196 271 407
ERK, activation, 7TM receptors      276—279
ERK, protein synthesis regulation      272—273 273
ERK, transcription activation      271—272 272
ERK1      274
ERK2      274
Erythropoietin      see “Epo”
Eserine      14
Excitation-contraction coupling      157 182
Exocytosis      157 179 181
Exocytosis, signalling pathways      289
Extracellular matrix      315 317 319 324
Extracellular signal regulated protein kinase      see “ERK”
F-actin      180
F-box      246
Fab fragments      316
FADD      339 350
FAK (focal adhesion kinase)      325 326 329 337
Fas      339
Fas ligand      339 339
FGF (fibroblast growth factor)      249
Fibrinogen      319
Fibroblast growth factor      see “FGF”
Fibronectin      317 325 328
FK506      154 188
FKBP      388
FKBP12      154 155 361 369
FKHRL      326
Flash      339
fMLP (formyl-Met-Leu-Phe)      354
Focal adhesion complexes      235 328—329 329
Focal adhesion kinase      see “FAK”
Follicle stimulating hormone      see “FSH”
Forskolin      117
Forskolin, adenylyl cyclase activation      109 112 116
Fos      208 209 271 272 276
FRAP/mTOR      308
FSH (follicle stimulating hormone)      20 22 195
Fura2      151 152
fyn      286 294 329
G kinase (cyclic GMP-dependent kinase)      178
G-proteins      42 72
G-proteins, $Ca^{2+}$-binding      149
G-proteins, $PLC\beta$ activation      123—124
G-proteins, $\alpha$-subunits      72 77 95—96 109
G-proteins, $\alpha$-subunits, $\beta\gamma$-subunit interactions      80 84 109
G-proteins, $\alpha$-subunits, adenylyl cyclase interaction      80 96 109 110 112 113
G-proteins, $\alpha$-subunits, diversity      79—80 79
G-proteins, $\alpha$-subunits, expression patterns      80
G-proteins, $\alpha$-subunits, functions      78 80
G-proteins, $\alpha$-subunits, sites interacting with membranes/proteins      80—82
G-proteins, $\alpha$-subunits, structural studies      81—82 81
G-proteins, $\beta\gamma$-subunits      72 82—85 95—96
G-proteins, $\beta\gamma$-subunits, functions      84
G-proteins, $\beta\gamma$-subunits, negative feedback signals      84—85
G-proteins, $\beta\gamma$-subunits, signal transmission      83—84
G-proteins, 7TM receptor linkage      72 73 99
G-proteins, activation without subunit dissociation      95—100
G-proteins, GTPase cycle      74—75 74
G-proteins, heterotrimeric      73—74 73
G-proteins, heterotrimeric, post-translational modifications      82 82 83
G-proteins, monomeric      73
G-proteins, monomeric, oncogene products      85—86
G-proteins, phototransduction      130 131
G-proteins, receptor affinity modulation      76 77
G0 phase      234
G1 phase      233 233 234 235—236 235 236
G2 phase      233 233 237—238 237
G2 phase, checkpoint      243 244
GABA ($\gamma$-aminobutyric acid)      24
GABA receptors      42 50 56
GABAA receptors      42
GABAB receptors      42 51
GABAB receptors, heterodimers      61
GABAC receptors      42
GAG      86
Gap junctions      165
GAP-43      200
Gastrin      19 20
GCAP (guanylyl cyclase activating protein)      136
GEFs (guanine nucleotide exchange factors)      95 197
Gelsolin      180 337
Geranylgeranyl groups, G-protein subunit post-translational modification      82 83
GH (growth hormone)      see “Somatotropin”
Glucagon      20 62
Glucagon, receptor binding      55
Gluconeogenesis      71
Glucose transport      307
GLUT4      307
Glutamate      19 24 133
Glutamate receptors      42 56
Glutamate receptors, iGlu      4 42
Glutamate receptors, ion channel linkage      50—51 158
Glutamate receptors, mGlu      42 51
Glutamate receptors, mGlu, homodimers      62
Glycine      24
Glycine receptors      50
Glycogen metabolism, PP1 regulation      386—388 386 387
Glycogen phosphorylase      191 191
Glycogen synthase      175 307 308 386 387
Glycogen synthase kinase      see “GSK”
Glycogen synthesis      107—108 108 306 307
Glycogenolysis      107 108 175 176 191—192 191 386 387
Glycogenolytic hormones      299
Glycosaminoglycans      324
GM-CSF (granulocyte-monocyte colony stimulating factor)      23 349
GM1      118 119
GnRH (gonadotrophin-releasing hormone)      3
Granulocyte-monocyte colony-stimulating factor      see “GM-CSF”
Grb2 (growth factor receptor binding protein-2)      269 277 287 329
Growth factors      22 225—251
Growth factors, multiple effects      19 22
Growth factors, nomenclature      232
Growth hormone (GH)      see “Somatotropin”
GSK (glycogen synthase kinase)      175 209
GSK-$3\beta$      307 333
GTP      71 72
GTP, stable analogues      76 76
GTP-binding proteins      2 71—100
GTP-binding proteins, 7TM receptor signalling      54
GTP-binding proteins, subunits      72
GTP-binding proteins, terminology      72—73
GTPase      72 90—91
GTPase activating G-protein      see “IRA”
GTPase, activation mechanisms      93—95 94
GTPase, GTP/GDP cycle      74—75 74
GTPase, regulation      75—76
Guanine nucleotide exchange factors      see “GEFs”
Guanylyl cyclase activating protein      see “GCAP”
H-Ras, Ha-Ras      86 211
Haemopoetic growth factor receptors      381
Haloperidol      61
Helper T lymphocytes      284 285 288
Hepatocyte growth factor      328
Heterologous desensitization      85 85
Histamine      20 23 212
Histamine, receptor binding      55
Histones      237 238
HIV (human immunodeficiency virus)      352
Homologous desensitization      85 85
Hormones      2 19 20 21
Hormones, cellular response measurement (EC50)      27 29
Hormones, definition      9
Hormones, historical background      4—8
Hormones, lipophilic      24—25
Hormones, multiple effects      19
1 2 3 4 5
blank
Ðåêëàìà
blank
blank
HR
@Mail.ru
       © Ýëåêòðîííàÿ áèáëèîòåêà ïîïå÷èòåëüñêîãî ñîâåòà ìåõìàòà ÌÃÓ, 2004-2024
Ýëåêòðîííàÿ áèáëèîòåêà ìåõìàòà ÌÃÓ | Valid HTML 4.01! | Valid CSS! Î ïðîåêòå